Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Linda Broer is active.

Publication


Featured researches published by Linda Broer.


Nature Communications | 2015

Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis (vol 5, 4926, 2014)

Beben Benyamin; Tonu Esko; Janina S. Ried; Aparna Radhakrishnan; Sita H. Vermeulen; Michela Traglia; Martin Goegele; Denise Anderson; Linda Broer; Clara Podmore; Jian'an Luan; Zoltán Kutalik; Serena Sanna; Peter van der Meer; Toshiko Tanaka; Fudi Wang; Harm-Jan Westra; Lude Franke; Evelin Mihailov; Lili Milani; Jonas Haelldin; Juliane Winkelmann; Thomas Meitinger; Joachim Thiery; Annette Peters; Melanie Waldenberger; Augusto Rendon; Jennifer Jolley; Jennifer Sambrook; Lambertus A. Kiemeney

Corrigendum: Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis


Nature Genetics | 2008

Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis.

Yurii S. Aulchenko; I A Hoppenbrouwers; Sreeram V. Ramagopalan; Linda Broer; Naghmeh Jafari; Jan Hillert; Jenny Link; Wangko Lundström; Eva Greiner; A. Dessa Sadovnick; Dirk Goossens; Christine Van Broeckhoven; Jurgen Del-Favero; George C. Ebers; Ben A. Oostra; Cornelia M. van Duijn; Rogier Q. Hintzen

The few loci associated with multiple sclerosis (MS) are all related to immune function. We report a GWA study identifying a new locus replicated in 2,679 cases and 3,125 controls. An rs10492972[C] variant located in the KIF1B gene was associated with MS with an odds ratio of 1.35 (P = 2.5 × 10−10). KIF1B is a neuronally expressed gene plausibly implicated in the irreversible axonal loss characterizing MS in the long term.


Human Molecular Genetics | 2014

Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age

Joris Deelen; Marian Beekman; Hae-Won Uh; Linda Broer; Kristin L. Ayers; Qihua Tan; Yoichiro Kamatani; Anna M. Bennet; Riin Tamm; Stella Trompet; Daníel F. Guðbjartsson; Friederike Flachsbart; Giuseppina Rose; Alexander Viktorin; Krista Fischer; Marianne Nygaard; Heather J. Cordell; Paolina Crocco; Erik B. van den Akker; Stefan Böhringer; Quinta Helmer; Christopher P. Nelson; Gary Saunders; Maris Alver; Karen Andersen-Ranberg; Marie E. Breen; Ruud van der Breggen; Amke Caliebe; Miriam Capri; Elisa Cevenini

The genetic contribution to the variation in human lifespan is ∼25%. Despite the large number of identified disease-susceptibility loci, it is not known which loci influence population mortality. We performed a genome-wide association meta-analysis of 7729 long-lived individuals of European descent (≥85 years) and 16 121 younger controls (<65 years) followed by replication in an additional set of 13 060 long-lived individuals and 61 156 controls. In addition, we performed a subset analysis in cases aged ≥90 years. We observed genome-wide significant association with longevity, as reflected by survival to ages beyond 90 years, at a novel locus, rs2149954, on chromosome 5q33.3 (OR = 1.10, P = 1.74 × 10−8). We also confirmed association of rs4420638 on chromosome 19q13.32 (OR = 0.72, P = 3.40 × 10−36), representing the TOMM40/APOE/APOC1 locus. In a prospective meta-analysis (n = 34 103), the minor allele of rs2149954 (T) on chromosome 5q33.3 associates with increased survival (HR = 0.95, P = 0.003). This allele has previously been reported to associate with low blood pressure in middle age. Interestingly, the minor allele (T) associates with decreased cardiovascular mortality risk, independent of blood pressure. We report on the first GWAS-identified longevity locus on chromosome 5q33.3 influencing survival in the general European population. The minor allele of this locus associates with low blood pressure in middle age, although the contribution of this allele to survival may be less dependent on blood pressure. Hence, the pleiotropic mechanisms by which this intragenic variation contributes to lifespan regulation have to be elucidated.


PLOS Genetics | 2012

Genome-Wide Association Study Identifies Novel Loci Associated with Circulating Phospho- and Sphingolipid Concentrations

Ayse Demirkan; Cornelia M. van Duijn; Peter Ugocsai; Aaron Isaacs; Peter P. Pramstaller; Gerhard Liebisch; James F. Wilson; Åsa Johansson; Igor Rudan; Yurii S. Aulchenko; Anatoly V. Kirichenko; A. Cecile J. W. Janssens; Ritsert C. Jansen; Carsten Gnewuch; Francisco S. Domingues; Cristian Pattaro; Sarah H. Wild; Inger Jonasson; Ozren Polasek; Irina V. Zorkoltseva; Albert Hofman; Lennart C. Karssen; Maksim Struchalin; James A B Floyd; Wilmar Igl; Zrinka Biloglav; Linda Broer; Arne Pfeufer; Irene Pichler; Susan Campbell

Phospho- and sphingolipids are crucial cellular and intracellular compounds. These lipids are required for active transport, a number of enzymatic processes, membrane formation, and cell signalling. Disruption of their metabolism leads to several diseases, with diverse neurological, psychiatric, and metabolic consequences. A large number of phospholipid and sphingolipid species can be detected and measured in human plasma. We conducted a meta-analysis of five European family-based genome-wide association studies (N = 4034) on plasma levels of 24 sphingomyelins (SPM), 9 ceramides (CER), 57 phosphatidylcholines (PC), 20 lysophosphatidylcholines (LPC), 27 phosphatidylethanolamines (PE), and 16 PE-based plasmalogens (PLPE), as well as their proportions in each major class. This effort yielded 25 genome-wide significant loci for phospholipids (smallest P-value = 9.88×10−204) and 10 loci for sphingolipids (smallest P-value = 3.10×10−57). After a correction for multiple comparisons (P-value<2.2×10−9), we observed four novel loci significantly associated with phospholipids (PAQR9, AGPAT1, PKD2L1, PDXDC1) and two with sphingolipids (PLD2 and APOE) explaining up to 3.1% of the variance. Further analysis of the top findings with respect to within class molar proportions uncovered three additional loci for phospholipids (PNLIPRP2, PCDH20, and ABDH3) suggesting their involvement in either fatty acid elongation/saturation processes or fatty acid specific turnover mechanisms. Among those, 14 loci (KCNH7, AGPAT1, PNLIPRP2, SYT9, FADS1-2-3, DLG2, APOA1, ELOVL2, CDK17, LIPC, PDXDC1, PLD2, LASS4, and APOE) mapped into the glycerophospholipid and 12 loci (ILKAP, ITGA9, AGPAT1, FADS1-2-3, APOA1, PCDH20, LIPC, PDXDC1, SGPP1, APOE, LASS4, and PLD2) to the sphingolipid pathways. In large meta-analyses, associations between FADS1-2-3 and carotid intima media thickness, AGPAT1 and type 2 diabetes, and APOA1 and coronary artery disease were observed. In conclusion, our study identified nine novel phospho- and sphingolipid loci, substantially increasing our knowledge of the genetic basis for these traits.


Journals of Gerontology Series A-biological Sciences and Medical Sciences | 2015

GWAS of Longevity in CHARGE Consortium Confirms APOE and FOXO3 Candidacy

Linda Broer; Aron S. Buchman; Joris Deelen; Daniel S. Evans; Jessica D. Faul; Kathryn L. Lunetta; Paola Sebastiani; Jennifer A. Smith; Albert V. Smith; Toshiko Tanaka; Lei Yu; Alice M. Arnold; Thor Aspelund; Emelia J. Benjamin; Philip L. De Jager; Gudny Eirkisdottir; Denis A. Evans; Melissa Garcia; Albert Hofman; Robert C. Kaplan; Sharon L.R. Kardia; Douglas P. Kiel; Ben A. Oostra; Eric S. Orwoll; Neeta Parimi; Bruce M. Psaty; Fernando Rivadeneira; Jerome I. Rotter; Sudha Seshadri; Andrew Singleton

BACKGROUND The genetic contribution to longevity in humans has been estimated to range from 15% to 25%. Only two genes, APOE and FOXO3, have shown association with longevity in multiple independent studies. METHODS We conducted a meta-analysis of genome-wide association studies including 6,036 longevity cases, age ≥90 years, and 3,757 controls that died between ages 55 and 80 years. We additionally attempted to replicate earlier identified single nucleotide polymorphism (SNP) associations with longevity. RESULTS In our meta-analysis, we found suggestive evidence for the association of SNPs near CADM2 (odds ratio [OR] = 0.81; p value = 9.66 × 10(-7)) and GRIK2 (odds ratio = 1.24; p value = 5.09 × 10(-8)) with longevity. When attempting to replicate findings earlier identified in genome-wide association studies, only the APOE locus consistently replicated. In an additional look-up of the candidate gene FOXO3, we found that an earlier identified variant shows a highly significant association with longevity when including published data with our meta-analysis (odds ratio = 1.17; p value = 1.85×10(-10)). CONCLUSIONS We did not identify new genome-wide significant associations with longevity and did not replicate earlier findings except for APOE and FOXO3. Our inability to find new associations with survival to ages ≥90 years because longevity represents multiple complex traits with heterogeneous genetic underpinnings, or alternatively, that longevity may be regulated by rare variants that are not captured by standard genome-wide genotyping and imputation of common variants.


Molecular Psychiatry | 2012

Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM

Najaf Amin; Enda M. Byrne; Julie Johnson; Georgia Chenevix-Trench; Stefan Walter; Ilja M. Nolte; J. M. Vink; R. Rawal; Massimo Mangino; A. Teumer; J. C. Keers; Germaine C. Verwoert; S. Baumeister; Reiner Biffar; Astrid Petersmann; N. Dahmen; A. Doering; Aaron Isaacs; Linda Broer; Naomi R. Wray; Grant W. Montgomery; Daniel Levy; Bruce M. Psaty; V. Gudnason; Aravinda Chakravarti; P. Sulem; D. F. Gudbjartsson; Lambertus A. Kiemeney; U. Thorsteinsdottir; K. Stefansson

Coffee consumption is a model for addictive behavior. We performed a meta-analysis of genome-wide association studies (GWASs) on coffee intake from 8 Caucasian cohorts (N=18 176) and sought replication of our top findings in a further 7929 individuals. We also performed a gene expression analysis treating different cell lines with caffeine. Genome-wide significant association was observed for two single-nucleotide polymorphisms (SNPs) in the 15q24 region. The two SNPs rs2470893 and rs2472297 (P-values=1.6 × 10−11 and 2.7 × 10−11), which were also in strong linkage disequilibrium (r2=0.7) with each other, lie in the 23-kb long commonly shared 5′ flanking region between CYP1A1 and CYP1A2 genes. CYP1A1 was found to be downregulated in lymphoblastoid cell lines treated with caffeine. CYP1A1 is known to metabolize polycyclic aromatic hydrocarbons, which are important constituents of coffee, whereas CYP1A2 is involved in the primary metabolism of caffeine. Significant evidence of association was also detected at rs382140 (P-value=3.9 × 10−09) near NRCAM—a gene implicated in vulnerability to addiction, and at another independent hit rs6495122 (P-value=7.1 × 10−09)—an SNP associated with blood pressure—in the 15q24 region near the gene ULK3, in the meta-analysis of discovery and replication cohorts. Our results from GWASs and expression analysis also strongly implicate CAB39L in coffee drinking. Pathway analysis of differentially expressed genes revealed significantly enriched ubiquitin proteasome (P-value=2.2 × 10−05) and Parkinsons disease pathways (P-value=3.6 × 10−05).


Nature Communications | 2015

Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome

Felix R. Day; David A. Hinds; Joyce Y. Tung; Lisette Stolk; Unnur Styrkarsdottir; Richa Saxena; Andrew Bjonnes; Linda Broer; David B. Dunger; Bjarni V. Halldórsson; Debbie A. Lawlor; Guillaume Laval; Iain Mathieson; Wendy L. McCardle; Yvonne V. Louwers; Cindy Meun; Susan M. Ring; Robert A. Scott; Patrick Sulem; André G. Uitterlinden; Nicholas J. Wareham; Unnur Thorsteinsdottir; Corrine K. Welt; Kari Stefansson; Joop S.E. Laven; Ken K. Ong; John R. B. Perry

Polycystic ovary syndrome (PCOS) is the most common reproductive disorder in women, yet there is little consensus regarding its aetiology. Here we perform a genome-wide association study of PCOS in up to 5,184 self-reported cases of White European ancestry and 82,759 controls, with follow-up in a further ∼2,000 clinically validated cases and ∼100,000 controls. We identify six signals for PCOS at genome-wide statistical significance (P<5 × 10−8), in/near genes ERBB4/HER4, YAP1, THADA, FSHB, RAD50 and KRR1. Variants in/near three of the four epidermal growth factor receptor genes (ERBB2/HER2, ERBB3/HER3 and ERBB4/HER4) are associated with PCOS at or near genome-wide significance. Mendelian randomization analyses indicate causal roles in PCOS aetiology for higher BMI (P=2.5 × 10−9), higher insulin resistance (P=6 × 10−4) and lower serum sex hormone binding globulin concentrations (P=5 × 10−4). Furthermore, genetic susceptibility to later menopause is associated with higher PCOS risk (P=1.6 × 10−8) and PCOS-susceptibility alleles are associated with higher serum anti-Müllerian hormone concentrations in girls (P=8.9 × 10−5). This large-scale study implicates an aetiological role of the epidermal growth factor receptors, infers causal mechanisms relevant to clinical management and prevention, and suggests balancing selection mechanisms involved in PCOS risk.


Journal of Human Genetics | 2009

Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis.

I A Hoppenbrouwers; Yurii S. Aulchenko; A. C. J. W. Janssens; Sreeram V. Ramagopalan; Linda Broer; Manfred Kayser; George C. Ebers; B. A. Oostra; C. M. van Duijn; R Q Hintzen

A recent genome-wide association study by the International Multiple Sclerosis Genetics Consortium (IMSGC) reported association of 17 single-nucleotide polymorphisms (SNPs) in 14 loci with multiple sclerosis (MS). Only two loci, HLA-DRA and IL2RA, reached genome-wide significance (P<5E−08). In our study, we determined whether we could replicate the results of the IMSGC and whether more SNPs are genome-wide significantly associated with MS. We assessed the association between the 17 IMSGC SNPs and MS in three cohorts (total number of subjects 3981, among these 1853 cases). We performed a meta-analysis of the results of our study, the original IMSGC results and the results of a recent replication study performed in the Australian population. Of the 17 IMSGC SNPs, five SNPs showed genome-wide significant association with MS: HLA-DRA (P=8E−124), IL7R (P=6E−09), IL2RA (P=1E−11), CD58 (P=4E−09) and CLEC16A (P=3E−12). Therefore, genome-wide significance has now been shown for SNPs in different non-HLA MS risk genes. Several of these risk genes, including CD58 and CLEC16A, are shared by different autoimmune diseases. Fine mapping studies will be needed to determine the functional contributions to distinct autoimmune phenotypes.


Annals of the Rheumatic Diseases | 2013

Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region

Marjolein J. Peters; Linda Broer; Hanneke L D M Willemen; Gudny Eiriksdottir; Lynne J. Hocking; Kate L. Holliday; Michael A. Horan; Ingrid Meulenbelt; Tuhina Neogi; Maria Popham; Carsten Schmidt; Anushka Soni; Ana M. Valdes; Najaf Amin; Elaine M. Dennison; Niels Eijkelkamp; Tamara B. Harris; Deborah J. Hart; Albert Hofman; Frank Huygen; Karen Jameson; Gareth T. Jones; Lenore J. Launer; Hanneke J. M. Kerkhof; Marjolein de Kruijf; John McBeth; Margreet Kloppenburg; William Ollier; Ben A. Oostra; Antony Payton

Background and objectives Chronic widespread pain (CWP) is a common disorder affecting ∼10% of the general population and has an estimated heritability of 48–52%. In the first large-scale genome-wide association study (GWAS) meta-analysis, we aimed to identify common genetic variants associated with CWP. Methods We conducted a GWAS meta-analysis in 1308 female CWP cases and 5791 controls of European descent, and replicated the effects of the genetic variants with suggestive evidence for association in 1480 CWP cases and 7989 controls. Subsequently, we studied gene expression levels of the nearest genes in two chronic inflammatory pain mouse models, and examined 92 genetic variants previously described associated with pain. Results The minor C-allele of rs13361160 on chromosome 5p15.2, located upstream of chaperonin-containing-TCP1-complex-5 gene (CCT5) and downstream of FAM173B, was found to be associated with a 30% higher risk of CWP (minor allele frequency=43%; OR=1.30, 95% CI 1.19 to 1.42, p=1.2×10−8). Combined with the replication, we observed a slightly attenuated OR of 1.17 (95% CI 1.10 to 1.24, p=4.7×10−7) with moderate heterogeneity (I2=28.4%). However, in a sensitivity analysis that only allowed studies with joint-specific pain, the combined association was genome-wide significant (OR=1.23, 95% CI 1.14 to 1.32, p=3.4×10−8, I2=0%). Expression levels of Cct5 and Fam173b in mice with inflammatory pain were higher in the lumbar spinal cord, not in the lumbar dorsal root ganglions, compared to mice without pain. None of the 92 genetic variants previously described were significantly associated with pain (p>7.7×10−4). Conclusions We identified a common genetic variant on chromosome 5p15.2 associated with joint-specific CWP in humans. This work suggests that CCT5 and FAM173B are promising targets in the regulation of pain.


International Journal of Epidemiology | 2014

Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markers

Joris Deelen; Marian Beekman; Veryan Codd; Stella Trompet; Linda Broer; Sara Hägg; Krista Fischer; Peter E. Thijssen; H. Eka D. Suchiman; Iris Postmus; André G. Uitterlinden; Albert Hofman; Anton J. M. de Craen; Andres Metspalu; Nancy L. Pedersen; Cornelia M. van Duijn; J. Wouter Jukema; Jeanine J. Houwing-Duistermaat; Nilesh J. Samani; P. Eline Slagboom

Background: Human leukocyte telomere length (LTL) decreases with age and shorter LTL has previously been associated with increased prospective mortality. However, it is not clear whether LTL merely marks the health status of an individual by its association with parameters of immune function, for example, or whether telomere shortening also contributes causally to lifespan variation in humans. Methods: We measured LTL in 870 nonagenarian siblings (mean age 93 years), 1580 of their offspring and 725 spouses thereof (mean age 59 years) from the Leiden Longevity Study (LLS). Results: We found that shorter LTL is associated with increased prospective mortality in middle (30–80 years; hazard ratio (HR) = 0.75, P = 0.001) and highly advanced age (≥90 years; HR = 0.92, P = 0.028), and show that this association cannot be explained by the association of LTL with the immune-related markers insulin-like growth factor 1 to insulin-like growth factor binding protein 3 molar ratio, C-reactive protein, interleukin 6, cytomegalovirus serostatus or white blood cell counts. We found no difference in LTL between the middle-aged LLS offspring and their spouses (β = 0.006, P = 0.932). Neither did we observe an association of LTL-associated genetic variants with mortality in a prospective meta-analysis of multiple cohorts (n = 8165). Conclusions: We confirm LTL to be a marker of prospective mortality in middle and highly advanced age and additionally show that this association could not be explained by the association of LTL with various immune-related markers. Furthermore, the approaches performed here do not further support the hypothesis that LTL variation contributes to the genetic propensity for longevity.

Collaboration


Dive into the Linda Broer's collaboration.

Top Co-Authors

Avatar

Albert Hofman

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Najaf Amin

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Ben A. Oostra

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joris Deelen

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Marian Beekman

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Fernando Rivadeneira

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Ana M. Valdes

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar

Ingrid Meulenbelt

Leiden University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge